LB PHARMACEUTICALS INC
(LBRX)Financial Statements · SEC EDGAR XBRL
Net Income
-$25.2M
+60.1%
EPS
$-3.13
+98.2%
FCF
-$35.3M
+34.5%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)